Birdwatch Archive

Birdwatch Note

2023-05-02 08:57:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Like many other medications, ivermectin has both human and veterinary uses. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/ Proven uses for ivermectin are all for the treatment of parasites. https://list.essentialmeds.org/medicines/58 https://www.cdc.gov/parasites/onchocerciasis/treatment.html https://www.nps.org.au/radar/articles/ivermectin-stromectol-for-typical-and-crusted-scabies https://www.tga.gov.au/news/media-releases/new-restrictions-prescribing-ivermectin-covid-19 The WHO, CDC, and other organizations encouraged clinical trials for ivermectin in COVID-19 https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.clinicaltrials.gov/ct2/results?cond=COVID-19&term=ivermectin&cntry=&state=&city=&dist=&Search=Search there is no evidence it works https://www.cochrane.org/CD015017/INFECTN_ivermectin-preventing-and-treating-covid-19

Written by AFC5C07D009FE4C54C28253564AB95C4ACD4F3E1BB017002587865A55AE6ACDE
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1429050070243192839

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1653322893173063685
  • noteId - 1653322893173063685
  • participantId -
  • noteAuthorParticipantId - AFC5C07D009FE4C54C28253564AB95C4ACD4F3E1BB017002587865A55AE6ACDE Participant Details
  • createdAtMillis - 1683017869643
  • tweetId - 1429050070243192839
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 1
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Like many other medications, ivermectin has both human and veterinary uses. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/ Proven uses for ivermectin are all for the treatment of parasites. https://list.essentialmeds.org/medicines/58 https://www.cdc.gov/parasites/onchocerciasis/treatment.html https://www.nps.org.au/radar/articles/ivermectin-stromectol-for-typical-and-crusted-scabies https://www.tga.gov.au/news/media-releases/new-restrictions-prescribing-ivermectin-covid-19 The WHO, CDC, and other organizations encouraged clinical trials for ivermectin in COVID-19 https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.clinicaltrials.gov/ct2/results?cond=COVID-19&term=ivermectin&cntry=&state=&city=&dist=&Search=Search there is no evidence it works https://www.cochrane.org/CD015017/INFECTN_ivermectin-preventing-and-treating-covid-19

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-05-02 08:57:49 UTC
(1683017869643)
1969-12-31 23:59:59 UTC
(-1)
2023-05-06 02:42:24 UTC
(1683340944665)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-05-03 08:26:53 -0500 Rating Details
2023-05-03 08:02:20 -0500 Rating Details
2023-05-03 07:03:04 -0500 Rating Details
2023-05-02 18:45:56 -0500 Rating Details
2023-05-02 18:45:22 -0500 Rating Details
2023-05-02 17:53:18 -0500 Rating Details
2023-05-02 16:15:47 -0500 Rating Details
2023-05-02 14:50:42 -0500 Rating Details
2023-05-02 14:25:28 -0500 Rating Details
2023-05-02 14:05:01 -0500 Rating Details
2023-05-02 14:03:42 -0500 Rating Details
2023-05-02 13:52:59 -0500 Rating Details
2023-05-02 12:47:59 -0500 Rating Details
2023-05-02 12:35:17 -0500 Rating Details
2023-05-02 11:52:22 -0500 Rating Details
2023-05-02 11:25:05 -0500 Rating Details
2023-05-02 11:02:46 -0500 Rating Details
2023-05-02 10:56:59 -0500 Rating Details
2023-05-02 10:50:40 -0500 Rating Details
2023-05-02 10:43:28 -0500 Rating Details
2023-05-02 10:41:40 -0500 Rating Details
2023-05-02 10:29:55 -0500 Rating Details
2023-05-02 10:06:55 -0500 Rating Details
2023-05-02 09:46:57 -0500 Rating Details
2023-05-02 08:58:00 -0500 Rating Details
2023-05-02 08:35:00 -0500 Rating Details
2023-05-02 07:37:05 -0500 Rating Details
2023-05-02 07:36:45 -0500 Rating Details
2023-05-02 07:34:40 -0500 Rating Details
2023-05-02 06:30:38 -0500 Rating Details
2023-05-02 06:29:30 -0500 Rating Details
2023-05-02 06:28:54 -0500 Rating Details
2023-05-02 06:01:50 -0500 Rating Details
2023-05-02 05:24:46 -0500 Rating Details
2023-05-02 05:13:07 -0500 Rating Details
2023-05-02 04:41:18 -0500 Rating Details
2023-05-02 04:31:36 -0500 Rating Details
2023-05-02 04:24:34 -0500 Rating Details
2023-05-02 07:36:45 -0500 Rating Details
2023-05-02 06:28:54 -0500 Rating Details
2023-05-02 10:29:55 -0500 Rating Details
2023-05-02 12:35:17 -0500 Rating Details
2023-05-02 10:06:55 -0500 Rating Details
2023-05-03 08:26:53 -0500 Rating Details
2023-05-02 14:25:28 -0500 Rating Details
2023-05-02 14:50:42 -0500 Rating Details
2023-05-02 12:47:59 -0500 Rating Details
2023-05-02 16:15:47 -0500 Rating Details
2023-05-02 04:41:18 -0500 Rating Details
2023-05-02 10:50:40 -0500 Rating Details
2023-05-02 10:41:40 -0500 Rating Details
2023-05-02 08:35:00 -0500 Rating Details
2023-05-02 05:13:07 -0500 Rating Details
2023-05-02 06:30:38 -0500 Rating Details
2023-05-02 11:25:05 -0500 Rating Details
2023-05-02 05:24:46 -0500 Rating Details
2023-05-02 13:52:59 -0500 Rating Details
2023-05-02 18:45:22 -0500 Rating Details
2023-05-02 14:05:01 -0500 Rating Details
2023-05-02 04:31:36 -0500 Rating Details
2023-05-02 18:45:56 -0500 Rating Details
2023-05-02 10:43:28 -0500 Rating Details
2023-05-02 06:29:30 -0500 Rating Details
2023-05-02 10:56:59 -0500 Rating Details
2023-05-02 07:34:40 -0500 Rating Details
2023-05-03 08:02:20 -0500 Rating Details
2023-05-02 07:37:05 -0500 Rating Details
2023-05-02 08:58:00 -0500 Rating Details
2023-05-02 04:24:34 -0500 Rating Details
2023-05-02 17:53:18 -0500 Rating Details
2023-05-03 07:03:04 -0500 Rating Details
2023-05-02 11:52:22 -0500 Rating Details
2023-05-02 11:02:46 -0500 Rating Details
2023-05-02 06:01:50 -0500 Rating Details
2023-05-02 14:03:42 -0500 Rating Details
2023-05-02 09:46:57 -0500 Rating Details
2023-05-22 09:29:51 -0500 Rating Details
2023-05-22 18:18:58 -0500 Rating Details
2023-06-06 10:51:54 -0500 Rating Details
2023-06-07 19:54:33 -0500 Rating Details
2023-06-25 08:40:37 -0500 Rating Details
2023-07-26 10:31:43 -0500 Rating Details
2023-08-08 08:24:10 -0500 Rating Details
2023-08-11 18:08:20 -0500 Rating Details
2023-08-11 09:26:33 -0500 Rating Details
2023-08-11 06:56:20 -0500 Rating Details
2023-08-13 16:15:19 -0500 Rating Details
2023-08-13 11:43:46 -0500 Rating Details
2023-08-13 10:58:00 -0500 Rating Details
2023-08-13 08:47:13 -0500 Rating Details
2023-08-13 07:44:06 -0500 Rating Details
2023-08-13 07:16:41 -0500 Rating Details
2023-08-13 06:39:31 -0500 Rating Details
2023-08-13 04:28:22 -0500 Rating Details
2023-08-13 03:08:13 -0500 Rating Details
2023-08-13 02:06:26 -0500 Rating Details
2023-08-13 00:34:57 -0500 Rating Details
2023-08-12 23:15:43 -0500 Rating Details
2023-08-12 22:35:22 -0500 Rating Details
2023-08-12 20:40:03 -0500 Rating Details
2023-08-12 20:13:07 -0500 Rating Details
2023-08-12 19:47:59 -0500 Rating Details
2023-08-12 19:21:18 -0500 Rating Details
2023-08-12 18:56:01 -0500 Rating Details
2023-08-12 16:31:57 -0500 Rating Details
2023-08-12 16:24:05 -0500 Rating Details
2023-08-12 16:00:11 -0500 Rating Details
2023-08-12 15:39:51 -0500 Rating Details
2023-08-12 15:35:52 -0500 Rating Details
2023-08-12 14:34:55 -0500 Rating Details
2023-08-12 14:05:36 -0500 Rating Details
2023-08-12 13:48:18 -0500 Rating Details
2023-08-12 08:27:43 -0500 Rating Details
2023-08-12 07:37:13 -0500 Rating Details
2023-08-12 07:07:03 -0500 Rating Details
2023-08-11 19:48:38 -0500 Rating Details
2023-08-14 06:59:36 -0500 Rating Details
2023-08-14 00:00:41 -0500 Rating Details
2023-08-13 23:24:07 -0500 Rating Details
2023-08-13 22:34:16 -0500 Rating Details
2023-08-15 13:12:20 -0500 Rating Details
2023-08-15 13:07:18 -0500 Rating Details
2023-08-15 12:29:01 -0500 Rating Details
2023-08-15 11:35:18 -0500 Rating Details
2023-08-16 18:03:40 -0500 Rating Details
2023-08-16 17:57:45 -0500 Rating Details
2023-08-16 13:23:35 -0500 Rating Details
2023-08-17 08:54:17 -0500 Rating Details
2023-08-21 01:20:24 -0500 Rating Details
2023-08-17 09:48:53 -0500 Rating Details
2023-08-16 17:57:42 -0500 Rating Details
2023-08-15 20:42:24 -0500 Rating Details
2023-08-15 18:39:07 -0500 Rating Details
2023-08-14 21:59:59 -0500 Rating Details
2023-08-13 11:32:16 -0500 Rating Details
2023-08-13 11:19:03 -0500 Rating Details
2023-08-13 11:08:00 -0500 Rating Details
2023-08-12 22:58:32 -0500 Rating Details
2023-08-12 18:57:32 -0500 Rating Details
2023-08-12 15:24:41 -0500 Rating Details
2023-08-12 09:17:17 -0500 Rating Details
2023-10-15 07:10:09 -0500 Rating Details
2023-12-03 20:09:34 -0600 Rating Details
2023-12-03 08:52:52 -0600 Rating Details
2024-02-11 08:52:15 -0600 Rating Details
2024-03-08 17:32:26 -0600 Rating Details
2024-03-09 19:52:51 -0600 Rating Details
2024-03-22 22:26:50 -0500 Rating Details
2024-03-22 21:27:29 -0500 Rating Details
2024-03-22 21:25:31 -0500 Rating Details
2024-03-22 19:52:17 -0500 Rating Details
2024-03-22 19:27:44 -0500 Rating Details
2024-03-22 17:36:02 -0500 Rating Details
2024-03-22 04:34:56 -0500 Rating Details
2024-03-23 18:17:00 -0500 Rating Details
2024-03-23 15:02:09 -0500 Rating Details
2024-03-23 07:52:45 -0500 Rating Details
2024-03-23 02:57:06 -0500 Rating Details
2024-03-23 02:33:12 -0500 Rating Details
2024-03-22 22:33:16 -0500 Rating Details
2024-03-23 21:33:14 -0500 Rating Details
2024-03-23 16:55:26 -0500 Rating Details
2024-03-23 14:44:05 -0500 Rating Details
2024-03-23 11:27:37 -0500 Rating Details
2024-03-23 10:50:45 -0500 Rating Details
2024-03-23 08:30:21 -0500 Rating Details
2024-03-23 05:25:49 -0500 Rating Details
2024-03-23 01:50:01 -0500 Rating Details
2024-03-22 19:07:56 -0500 Rating Details
2024-03-22 18:17:09 -0500 Rating Details
2024-03-22 17:58:43 -0500 Rating Details
2024-03-22 17:43:34 -0500 Rating Details
2024-03-22 14:19:42 -0500 Rating Details
2024-03-22 13:57:15 -0500 Rating Details
2024-03-22 13:31:12 -0500 Rating Details
2024-03-22 06:52:23 -0500 Rating Details
2024-03-22 02:13:07 -0500 Rating Details
2024-03-22 00:40:38 -0500 Rating Details
2024-03-14 08:14:01 -0500 Rating Details
2024-03-23 06:39:17 -0500 Rating Details
2024-03-23 06:22:05 -0500 Rating Details
2024-03-23 05:34:23 -0500 Rating Details
2024-03-23 00:20:21 -0500 Rating Details
2024-03-22 23:15:41 -0500 Rating Details
2024-03-22 19:37:25 -0500 Rating Details
2024-03-22 19:21:54 -0500 Rating Details
2024-03-22 18:37:48 -0500 Rating Details
2024-03-22 18:27:55 -0500 Rating Details
2024-03-22 18:16:06 -0500 Rating Details
2024-03-22 17:57:21 -0500 Rating Details
2024-03-22 17:54:24 -0500 Rating Details
2024-03-22 17:37:13 -0500 Rating Details
2024-03-22 15:18:33 -0500 Rating Details
2024-03-22 02:35:07 -0500 Rating Details
2024-03-22 01:48:19 -0500 Rating Details
2024-03-22 01:47:55 -0500 Rating Details
2024-03-28 13:34:11 -0500 Rating Details
2024-03-31 18:50:19 -0500 Rating Details
2024-03-31 16:36:00 -0500 Rating Details
2024-04-01 21:14:59 -0500 Rating Details
2024-04-02 02:06:13 -0500 Rating Details
2024-04-01 16:12:38 -0500 Rating Details
2024-04-01 11:28:39 -0500 Rating Details
2024-04-01 10:51:11 -0500 Rating Details